• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

NeoMed

edit

NeoMed Management is an international investment firm, exclusively focussing on the healthcare and life science industry. Founded in 1996, NeoMed has established four funds, with total committed capital exceeding $200 million.

NeoMed has a multi-stage investment approach and invests at all stages of development from start-up to later stage growth financings. Since inception, NeoMed has backed more than 30 companies in the USA and Europe, including Scandinavia, Switzerland, Germany and the UK.

Milestones

edit

• 
  NeoMed invested in NovaShunt. (3/9/11)
  Posted 3/9/11 at 5:57am via prnewswire.com
• 
  NeoMed invested in Kuros Biosurgery. (10/1/05)
  Posted 8/31/10 at 12:41am via kuros.ch
• 
  NeoMed invested in Kuros Biosurgery. (1/1/05)
  Posted 8/30/10 at 2:46am via kuros.ch
• 
  NeoMed invested in Endosense. (10/27/09)
  Posted 10/28/09 at 3:18am via onbiovc.com
• 
  NeoMed invested in Diagnoplex. (12/13/08)
  Posted 6/16/09 at 12:40am via bio-medicine.org

Investments

Videos

Sources

1. NovaShunt AG Raises $25 Million in a Series B Financing Co-Led by BioMedInvest AG, Entrepreneurs Fund and Capricorn Health-tech Fund (prnewswire.com) [edit]
2. Endosense, SA: Series B $36M (onbiovc.com) [edit]
3. Diagnoplex Closes CHF10 Million ($8.3 Million) Series A Financing (bio-medicine.org) [edit]
4. KUROS BIOSURGERY AG RAISES CHF 5.6M (€ 3.6M) IN ADDITIONAL FUNDING (kuros.ch) [edit]
5. KUROS BIOSURGERY AG EXERCISES OPTION FOR CHF 6.1M (€ 4M) INVESTMENT (kuros.ch) [edit]